VTI is developing the first human liver cell-based Extracorporeal Liver Assist Device (ELAD) to stabilize liver function in patients with severe liver failure.
What does ELAD stand for?
ELAD stands for Extracorporeal Liver Assist Device (artificial liver)
This definition appears frequently and is found in the following Acronym Finder categories:
- Science, medicine, engineering, etc.
See other definitions of ELAD
We have 2 other meanings of ELAD in our Acronym Attic
- English Language Learners Advisory Committees
- English Learner Advisory Committee (California State Board of Education)
- Espace Lausannois d'Art Contemporain (French: Lausanne Space for Contemporary Art; Lausanne, Switzerland)
- Extraneous Logical and in Expression Used as Branch Condition (software fault)
- East Los Angeles Community Corporation
- Especialización en Cooperación Internacional para el Desarrollo (Spanish: Specialization in International Cooperation for Development; degree)
- Extended Life Attitude Control System (spacecraft)
- Electronics for Actuators and Integrated Systems (Switzerland)
- English Language Acquisition Department (Arizona and Louisiana)
- Equivalent Level Annual Dividend (insurance)
- Electronic Lodgement and Delivery Service (Australia Post)
- Emacs (Editor Macros) Lisp Archive Entry (computing)
- English Language Assessment Examination
- European Loss Adjusting Expert
- Excessive Leather Accessories for Firefighters (Facebook fan page)
- E-Learning Advisory Group (UK)
- European Library Automation Group
- Enzyme-Linked, Amplicon Hybridization Assay
- Everybody Loves A Happy Ending (Tears for Fears music album)
- Export License Application and Information Network
Samples in periodicals archive:
The device called Extracorporeal Liver Assist Device, or ELAD uses immortalized human liver cells.
San Diego, CA, (VTI) announced patient enrollment has begun for a randomized, controlled, multi-center, Phase 2 clinical trial that will study the Extracorporeal Liver Assist Device (ELAD) as a treatment for patients with Acute Liver Failure (ALF) under three protocols.
has worldwide rights to patents issued or pending covering a portfolio of technologies, including its two extracorporeal liver assist devices, which are in preclinical development.
The ELAD Artificial Liver is an extracorporeal liver assist device designed to provide temporary hepatic replacement therapy for patients with FHF until their own liver can regenerate or sustain patients until a suitable organ becomes available.
Synteract uses SAS to manage data for Vitagen's artificial liver device, the Extracorporeal Liver Assist Device (ELAD) system.
The proceeds of the financing will enable the Company to initiate further clinical studies of the Extracorporeal Liver Assist Device (ELAD(R)) system, the first human liver cell-based therapy that provides important metabolic support for patients with severe liver failure by eliminating toxins and synthesizing many of the proteins that are key products of normal human liver function.
Sheryl Orlyk, 34, a mother of 3 from suburban Chicago, Ill, was the first to use the extracorporeal liver assist device (ELAD) developed by the Vitagen Company of LaJolla, Cal.